Stephen M. Chang

Stephen M. Chang

Chief Tech/Sci/R&D Officer at One Med Research Institute

68 year
Health Technology
Health Services
Consumer Services

Profile

Stephen M.
Chang
was the founder of Asterand Biosciences, Inc. founded in 2006, where he held the title of Chief Scientific Officer.
Currently, he is the Director-Research at One Med Research Institute.
He was also the Chief Scientific Officer & Vice President at Canji, Inc. and Schering-Plough Research Institute from 1998 to 2004.
Additionally, he held the title of Senior Vice President-Strategic Initiatives at New York Stem Cell Foundation, Inc. and Chief Scientific Officer at Stemgent, Inc. Dr. Chang received his doctorate from the University of California, Irvine and his undergraduate degree from the University of Michigan.

Stephen M. Chang active positions

CompaniesPositionStart
One Med Research Institute Chief Tech/Sci/R&D Officer -
All active positions of Stephen M. Chang

Former positions of Stephen M. Chang

CompaniesPositionEnd
HISTOGEN INC. Director/Board Member 2021-03-23
MultiCell Immunotherapeutics, Inc. President 2007-12-20
Chief Tech/Sci/R&D Officer 2003-12-31
Chief Tech/Sci/R&D Officer 2003-12-31
Corporate Officer/Principal -
See the detail of Stephen M. Chang's experience

Training of Stephen M. Chang

University of California, Irvine Doctorate Degree
University of Michigan Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stephen M. Chang's experience

Connections

24

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
MULTICELL TECHNOLOGIES, INC.

Health Technology

HISTOGEN INC.

Health Technology

Private companies8

Health Technology

Health Services

Health Technology

Health Services

MultiCell Immunotherapeutics, Inc.

New York Stem Cell Foundation, Inc.

Miscellaneous

Health Technology

One Med Research Institute

See company connections
  1. Stock Market
  2. Insiders
  3. Stephen M. Chang